Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. thoracic surgery
Show results for
Products
Services
Applications

Companies

News
Articles
Downloads
Videos

Refine by
Date

  • Older

Thoracic Surgery Articles & Analysis: Older

32 news found

Practicing in the Digital Age: The Benefits of the SurgiCam HD

Practicing in the Digital Age: The Benefits of the SurgiCam HD

Summary The SurgiCam® HD, a specialized point-of-view camera designed for clinicians, plays a pivotal role in the documentation, education, and analysis of surgical, dental, and veterinary procedures. Its high-quality image and video capturing capabilities make it an indispensable tool in these fields. This innovative camera significantly enhances surgical practices, education, and research ...

BySurgiTel is a Division of General Scientific Corporation (GSC)


CONMED Completes Acquisition of Biorez, Inc.

CONMED Completes Acquisition of Biorez, Inc.

The Company’s products are used by surgeons and physicians in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. For more information, visit www.conmed.com. ...

ByBiorez Inc.


CONMED Announces Definitive Agreement to Acquire Biorez, Inc.

CONMED Announces Definitive Agreement to Acquire Biorez, Inc.

The Company’s products are used by surgeons and physicians in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. For more information, visit www.conmed.com. ...

ByBiorez Inc.


XyloCor Therapeutics Achieves Target Enrollment in Phase 2 EXACT Study of XC001 Novel Gene Therapy for Ischemic Heart Disease

XyloCor Therapeutics Achieves Target Enrollment in Phase 2 EXACT Study of XC001 Novel Gene Therapy for Ischemic Heart Disease

Positive Phase 1 results reported at the American Association for Thoracic Surgery (AATS) and the American Society of Gene and Cell Therapy (ASGCT) revealed XC001 is well tolerated at all dose levels Phase I data support XC001 therapeutic effect and potential dose response Topline Phase 2 data readout expected in February 2023 with interim results in the ...

ByXyloCor Therapeutics


XyloCor Therapeutics Announces Presentation of Preliminary Clinical Data from Phase 1 Portion of the EXACT Phase 1/2 Study of XC001 Novel Gene Therapy for Refractory Angina at AATS and ASGCT

XyloCor Therapeutics Announces Presentation of Preliminary Clinical Data from Phase 1 Portion of the EXACT Phase 1/2 Study of XC001 Novel Gene Therapy for Refractory Angina at AATS and ASGCT

Data from the Phase 1 dose-escalation portion of the Phase 1/2 EXACT study demonstrate XC001 was well-tolerated at all dose levels tested; highest dose level evaluated selected for ongoing Phase 2 portion of the study – Preliminary efficacy data highlight XC001 potential for patients with refractory angina with no other treatment options – Treatment strategy is to use local ...

ByXyloCor Therapeutics


Deborah Heart and Lung Center Introduces the Ivenix Infusion System to the Hospital

Deborah Heart and Lung Center Introduces the Ivenix Infusion System to the Hospital

“This will have a significant impact on our ability to provide high-quality care and ensure our patients get the rest needed after surgery.” She added, “We continue to invest in smart technology, and this was a natural next step for us. ...

ByIvenix, Inc.


World`s First Use of Lightpoint Medical`s Robotic Gamma Probe in Lung Surgery Performed in the U.S.

World`s First Use of Lightpoint Medical`s Robotic Gamma Probe in Lung Surgery Performed in the U.S.

Doug Adams, a specialist in robotic thoracic surgery at Bethesda North Hospital (part of TriHealth, Ohio) performed a first-in-the-world lung procedure with SENSEI, the company's new miniature robotic gamma probe. ...

ByLightpoint Medical, Ltd


Versius launched in Poland as CMR expands presence across region

Versius launched in Poland as CMR expands presence across region

At Salve Medica, Versius is being used in urology, with plans to expand into general surgery and gynaecology as part of a multispecialty robotics programme. ...

ByCMR Surgical Ltd


Versius introduced in leading public hospitals in Egypt

Versius introduced in leading public hospitals in Egypt

At IHUN, Versius has been used in urological surgery. Using robotic keyhole surgery in these cases may reduce recovery time for a patient when compared to open surgery and can significantly reduce physical strain of operating for the surgeon. ...

ByCMR Surgical Ltd


Versius has indication extended into thoracic surgery

Versius has indication extended into thoracic surgery

CMR Surgical (CMR) today announced the Versius Surgical Robotic System® has been indicated for thoracics to support surgeons providing minimally invasive surgery to patients undergoing operations in the lungs, thymus and oesophagus. ...

ByCMR Surgical Ltd


CytoSorbents Appoints Daniel Wendt, MD, PhD, MHBA, FECTS as Vice President, Medical Affairs Cardiovascular

CytoSorbents Appoints Daniel Wendt, MD, PhD, MHBA, FECTS as Vice President, Medical Affairs Cardiovascular

Wendt serves as Co-director of the Thoracic and Cardiovascular Surgery Clinic, West German Heart and Vascular Center in Essen, Germany and is Professor of Cardiac Surgery at Essen University Medical School. ...

ByCytoSorbents Corporation


Versius surgical robot used for first time in an Italian public hospital

Versius surgical robot used for first time in an Italian public hospital

Within the hospital, Versius will be used in a multi-specialty robotics programme including thoracic and general surgery. The Italian surgical robotics market is one of the most significant in Europe with cutting-edge technologies being increasingly adopted. ...

ByCMR Surgical Ltd


Biostage Hires David Green as Chief Executive Officer

Biostage Hires David Green as Chief Executive Officer

Dennis Wigle, M.D., Ph.D and Chair of Thoracic Surgery at the Mayo Clinic, was approved under the FDA's E-IND ("compassionate use") protocol, and was published in JTO Clinical and Research Reports in August this year. ...

ByHarvard Apparatus Regenerative Technology, Inc. formely known as Biostage, Inc.


CytoSorbents Announces Availability of Preliminary Data Abstracts from Two Endocarditis Studies, including the REMOVE study, to be Presented at the EACTS Conference

CytoSorbents Announces Availability of Preliminary Data Abstracts from Two Endocarditis Studies, including the REMOVE study, to be Presented at the EACTS Conference

CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using blood purification, announced the public availability of preliminary data abstracts from two separate endocarditis studies, including the REMOVE study, to be presented at the upcoming European Association for ...

ByCytoSorbents Corporation


CELLVIE featured in Biocentury`s Emerging Company Profile

CELLVIE featured in Biocentury`s Emerging Company Profile

During his time at Adhesys, he interacted with Pedro del Nido, chairman of the Department of Cardiac Surgery at Boston Children's Hospital, whom he had "always wanted to work with." ...

Bycellvie Inc.


CorWave Presented First Successful In Vivo 60-Day Study on Its Innovative LVAD Cardiac Support Device

CorWave Presented First Successful In Vivo 60-Day Study on Its Innovative LVAD Cardiac Support Device

Professor Pascal Leprince, Head of Cardiac and Thoracic Surgery at the AP-HP Pitié-Salpêtrière Hospital and Professor at the Sorbonne University Faculty of Medicine, commented, “The recent ESAO communication by CorWave on chronic animal trialsshows this new generation pump is very promising and will continue to move the LVAD field toward ...

ByCorWave


CARMAT announces the second center implanting its total artificial heart in the United States

CARMAT announces the second center implanting its total artificial heart in the United States

Slaughter, Professor and Chair of the Department of Cardiovascular and Thoracic Surgery at the University of Louisville and UofL Physician at Jewish Hospital, Louisville, Kentucky. ...

ByCarmat


Xeltis initiates first-ever pivotal trial of a synthetic restorative pulmonary heart valve

Xeltis initiates first-ever pivotal trial of a synthetic restorative pulmonary heart valve

“Regenerating living heart valves in patients requiring RVOT reconstruction may substantially change their quality of life,” said David Morales, M.D., Director, Congenital Heart Surgery, Cincinnati Children’s Hospital and Professor, Department of Pediatrics at University of Cincinnati, who is global principal investigator of the trial. ...

ByXELTIS BV


BioStable Science & Engineering Announces CE Mark Approval for the HAART 200 Aortic Annuloplasty Device & Surpasses 1,000 Patients Treated Worldwide with the HAART Devices

BioStable Science & Engineering Announces CE Mark Approval for the HAART 200 Aortic Annuloplasty Device & Surpasses 1,000 Patients Treated Worldwide with the HAART Devices

Approximately 53% of BAV patients require aortic valve surgery within 25 years of being diagnosed.[1] Most BAV patients undergo aortic valve replacement between 40 and 60 years of age, subjecting them to increased risk of reoperation or complications associated with valve replacement technologies. [2] Valve repair is an attractive alternative to valve replacement for bicuspid ...

ByBioStable Science & Engineering, Inc.


Preclinical results of AdjuCor’s technology to be presented at the upcoming 101st annual meeting of the American Association for Thoracic Surgery (AATS)

Preclinical results of AdjuCor’s technology to be presented at the upcoming 101st annual meeting of the American Association for Thoracic Surgery (AATS)

In another great achievement for AdjuCor’s ground-breaking new technology within a short period of time, its submitted abstract has been accepted for presentation at the prestigious 101st American Association for Thoracic Surgery (#AATS2021). Prof. Stephan Schueler will be presenting specifics relating to the augmentation technology. ...

ByAdjuCor GmbH

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT